Kun-Ho Yoon

33PUBLICATIONS
72CO-AUTHORS
GlycobiologyFood engineeringMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Mar 21, 2026
β-cell recovery revisited: Is prediabetes remission driven by insulin sensitivity or β-cell function?

Joonyub Lee, Kun-Ho Yoon

|Nov 14, 2025
Lobeglitazone improves glycaemic control as add-on therapy to empagliflozin plus metformin in patients with type 2 diabetes mellitus: A double-blind, randomised, placebo-controlled trial.

Da Hea Seo, Kyung Wan Min, Ho Sang Sohn

|Oct 21, 2025
Metabolic Syndrome and Risk of Moyamoya Vasculopathy and Subsequent Stroke in Young Adults.

Joonyub Lee, Minwoo Lee, Seung-Hwan Lee

|Jul 29, 2025
Efficacy and safety of lobeglitazone added to metformin and sitagliptin combination therapy in patients with type 2 diabetes: A 52-week, multicentre, randomized, placebo-controlled, phase III clinical trial.

Eun-Gyoung Hong, Kyung-Wan Min, SungWan Chun

|Aug 06, 2024
Islet transplantation in Korea.

Joonyub Lee, Kun-Ho Yoon

|Mar 08, 2024
A 52-week efficacy and safety study of enavogliflozin versus dapagliflozin as an add-on to metformin in patients with type 2 diabetes mellitus: ENHANCE-M extension study.

Tae Seo Sohn, Kyung-Ah Han, Yonghyun Kim

Pageof 6

Frequent Collaborators

5 joint publications

Wayne Huey-Herng Sheu

4 joint publications

Eun Young Lee

3 joint publications

Linong Ji

3 joint publications

Yeoree Yang